{
  "disease_name": "Mucopolysaccharidosis type 4",
  "orpha_code": "582",
  "trials": [
    {
      "nctId": "NCT02716246",
      "briefTitle": "Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH",
      "officialTitle": "Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA",
      "overallStatus": "RECRUITING",
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "MPS IIIA",
        "Sanfilippo Syndrome",
        "Sanfilippo A",
        "Mucopolysaccharidosis III"
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "UX111"
        },
        {
          "type": "DRUG",
          "name": "Prophylactic Immunomodulatory (IM) Therapy"
        },
        {
          "type": "DRUG",
          "name": "Optimized Prophylactic IM Therapy"
        },
        {
          "type": "DRUG",
          "name": "Adjuvant IM Therapy"
        }
      ],
      "enrollment": 36,
      "locations": [
        {
          "facility": "Nationwide Children's Hospital",
          "city": "Columbus",
          "country": "United States"
        },
        {
          "facility": "Children's Hospital of Pittsburgh",
          "city": "Pittsburgh",
          "country": "United States"
        },
        {
          "facility": "Women's and Children's Hospital",
          "city": "North Adelaide",
          "country": "Australia"
        },
        {
          "facility": "Vall d'Hebron Barcelona Hospital Campus",
          "city": "Barcelona",
          "country": "Spain"
        },
        {
          "facility": "Hospital Cl√≠nico Universitario de Santiago",
          "city": "Santiago De Compostela",
          "country": "Spain"
        }
      ],
      "lastUpdateDate": "2025-06-15"
    }
  ],
  "processing_timestamp": "2025-07-07T03:13:03.752389",
  "run_number": 1,
  "total_trials_found": 1
}